[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:lead-pharma-medicine-bv-09172969:header:guest:personal:":3,"case:lead-pharma-medicine-bv-09172969:overview:guest:personal::{}":79,"case:lead-pharma-medicine-bv-09172969:related":416},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":31,"termination_reason":32,"kvk_number":33,"legal_form":34,"sbi":14,"court":37,"judge":40,"judge_source":41,"curator":42,"location":46,"counts":56,"pages":61,"follower_count":60,"report_count":57,"last_report_on":73,"last_update_at":74,"freshness":75,"linked":78},"01M3SJFSJCWBFFNRZ7ERDWZQ0C","lead-pharma-medicine-bv-09172969","Lead Pharma Medicine B.V.",[],"terminated","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.01\u002F25\u002F159","2025-06-17","2026-09-29","lack_of_assets","09172969",{"value":35,"source":36},"BV","cir",{"name":38,"slug":39,"location":14},"Rechtbank Oost-Brabant","oost-brabant","mr. S.C.E.F. Moulen Janssen",{"type":36,"report_number":14,"published_on":14},{"name":43,"slug":44,"law_firm":14,"city":14,"verified":45},"mr. D.P. Schalken","dp-schalken",false,{"street":47,"house_number":48,"addition":49,"postal_code":50,"city":51,"municipality":51,"province":52,"lat":53,"lng":54,"kind":55,"source":36},"Kloosterstraat","9","RK","5349AB","Oss","Noord-Brabant",51.760717,5.533719,"business",{"reports":57,"documents":58,"assets":59,"investigations":59,"news":60},4,13,6,0,{"overview":62,"reports":64,"financials":65,"investigations":66,"assets":67,"timeline":68,"documents":69,"news":70,"company":71,"compare":72},{"index":63,"ads":63},true,{"index":63,"ads":63},{"index":63,"ads":63},{"index":63,"ads":45},{"index":63,"ads":45},{"index":63,"ads":45},{"index":63,"ads":45},{"index":45,"ads":45},{"index":63,"ads":45},{"index":45,"ads":45},"2026-04-08","2026-10-04T17:34:33+00:00",{"last_checked_at":76,"last_reconciled_at":76,"stale":45,"status":77},"2026-10-11T04:06:37+00:00","current",{"continued_from":14,"continued_as":14},{"data":80},{"summary":81,"changes":148,"kpis":238,"topics":272,"topics_report_number":57,"topics_report_date":73,"processing":14,"timeline":339,"documents":396,"sources":412,"curator_update":14,"news":414,"auctions":415,"auction_count":60},{"kind":82,"category":82,"sentences":83,"facts":127,"published_at":147},"template",[84,89,92,96,101,109,115,121],{"key":85,"params":86,"facts":87},"declared",{"procedure":9,"date":30,"court":38,"number":29},[88],"procedure",{"key":8,"params":90,"facts":91},{"date":31},[8],{"key":93,"params":94,"facts":95},"curator",{"name":43},[93],{"key":20,"params":97,"facts":100},{"count":98,"number":14,"date":99},9,"2026-08-11",[20],{"key":102,"params":103,"facts":107},"value",{"field":104,"value":105,"state":106,"qualifier":14,"number":57,"date":73},"estate_assets",315857.06,"known",[108],"value_estate_assets",{"key":102,"params":110,"facts":113},{"field":111,"value":112,"state":106,"qualifier":14,"number":57,"date":73},"concurrent_claims",680175.99,[114],"value_concurrent_claims",{"key":102,"params":116,"facts":119},{"field":117,"value":118,"state":106,"qualifier":14,"number":57,"date":73},"creditor_count",21,[120],"value_creditor_count",{"key":102,"params":122,"facts":125},{"field":123,"value":124,"state":106,"qualifier":14,"number":57,"date":73},"preferential_claims",580086.57,[126],"value_preferential_claims",{"company":128,"procedure":130,"terminated":131,"curator":132,"reports":133,"value_estate_assets":134,"value_concurrent_claims":138,"value_creditor_count":141,"value_preferential_claims":144},{"category":129},"official",{"category":129},{"category":129},{"category":129},{"category":129},{"category":135,"value_id":136,"reference_id":137},"automated",45712,372179,{"category":135,"value_id":139,"reference_id":140},13651,318122,{"category":135,"value_id":142,"reference_id":143},13650,318121,{"category":135,"value_id":145,"reference_id":146},13652,318123,"2026-10-09T07:57:19+00:00",{"from":149,"to":153,"count":155,"groups":156},{"id":150,"number":151,"published_on":152},"01M3SJFZZX1K9WBY6WZ9W86CVW",3,"2026-01-14",{"id":154,"number":57,"published_on":73},"01M3SJG4ZHENMD35XVB72FSVJQ",7,{"new":157,"changed":158,"completed":224,"ongoing":236,"no_longer_mentioned":237},[],[159,180,192,204,212,219],{"kind":160,"field":111,"change":161,"from":162,"to":164,"delta":165,"delta_ratio":166,"source":167},"amount","changed",{"value":163,"state":106,"qualifier":14},669975.99,{"value":112,"state":106,"qualifier":14},10200,0.0152,{"id":140,"category":135,"method":168,"source_type":169,"document":170,"page":175,"section":176,"excerpt":177,"certainty":178,"curator_verified_at":14,"processed_at":179},"deterministic","cir_report",{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"01M3SJG6EV72GZJ4NWXZ6V4RQB","Verslag: 08-04-2026",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG6EV72GZJ4NWXZ6V4RQB.pdf",15,"8.6 Bedrag concurrente crediteuren","€ 662.535,77 Toelichting Van dit bedrag bestaat EUR 625.393,20 uit voorafgaand aan faillietverklaring verschuldigde huurpenningen. De huurbetaling w as als gevolg van een eind 2024 gemaakte afspraak met de verhuurder uitgesteld.",0.95,"2026-10-02T18:43:03+00:00",{"kind":181,"field":117,"change":161,"from":182,"to":184,"delta":185,"delta_ratio":186,"source":187},"count",{"value":183,"state":106,"qualifier":14},20,{"value":118,"state":106,"qualifier":14},1,0.05,{"id":143,"category":135,"method":168,"source_type":169,"document":188,"page":189,"section":190,"excerpt":191,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},14,"8.5 Aantal concurrente crediteuren","7",{"kind":193,"topic":194,"change":161,"from":195,"to":196,"source":197},"topic","bookkeeping_duty","investigating","mentioned",{"id":198,"category":135,"method":168,"source_type":169,"document":199,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},318135,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},11,"7.1 Boekhoudplicht","Voldaan.",0.5,{"kind":193,"topic":205,"change":161,"from":195,"to":196,"source":206},"director_liability",{"id":207,"category":135,"method":168,"source_type":169,"document":208,"page":209,"section":210,"excerpt":211,"certainty":203,"curator_verified_at":14,"processed_at":179},318136,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},12,"7.5 Onbehoorlijk bestuur","Toelichting Er is geen sprake van onbehoorlijk bestuur. De gemaakte intercompany-afspraken over de toebedeling van kosten en activa binnen het concern w erd achterhaald door het uitgesproken faillissement van Lead Pharma Holding B.V.",{"kind":193,"topic":213,"change":161,"from":195,"to":196,"source":214},"paulianas",{"id":215,"category":135,"method":168,"source_type":169,"document":216,"page":209,"section":217,"excerpt":218,"certainty":203,"curator_verified_at":14,"processed_at":179},318137,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"7.6 Paulianeus handelen","Nee Toelichting Er is geen sprake van paulianeus handelen.",{"kind":193,"topic":220,"change":161,"from":195,"to":196,"source":221},"legality_review",{"id":222,"category":135,"method":168,"source_type":169,"document":223,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},318138,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},[225],{"kind":193,"topic":226,"change":227,"from":196,"to":227,"source":228},"causes_investigation","completed",{"id":229,"category":135,"method":168,"source_type":169,"document":230,"page":231,"section":232,"excerpt":233,"certainty":234,"curator_verified_at":14,"processed_at":235},134802,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},5,"1.5 Oorzaak faillissement","Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du",0.7,"2026-09-30T16:31:29+00:00",[],[],{"values":239,"reports":268},[240,251,255,261,265],{"field":104,"kind":160,"value":105,"state":106,"qualifier":14,"as_of":73,"category":135,"report_number":57,"report_date":73,"source":241,"previous":248,"delta":250,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":137,"category":135,"method":168,"source_type":169,"document":242,"page":59,"section":246,"excerpt":247,"certainty":178,"curator_verified_at":14,"processed_at":74},{"id":243,"title":244,"report_number":57,"report_date":73,"published_on":73,"page_count":98,"url":245,"available":63},"01M3SJG4YYAPBHX0ZT5CMQ61T4","Financieel verslag 08-04-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG4YYAPBHX0ZT5CMQ61T4.pdf","financial_statement_a","Totaal baten                                         € 315.857,06                      € 54.548,53",{"value":249,"state":106,"report_number":151,"report_date":152},315647.65,209.41,{"field":111,"kind":160,"value":112,"state":106,"qualifier":14,"as_of":73,"category":135,"report_number":57,"report_date":73,"source":252,"previous":254,"delta":165,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":140,"category":135,"method":168,"source_type":169,"document":253,"page":175,"section":176,"excerpt":177,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"value":163,"state":106,"report_number":151,"report_date":152},{"field":123,"kind":160,"value":124,"state":106,"qualifier":14,"as_of":73,"category":135,"report_number":57,"report_date":73,"source":256,"previous":260,"delta":60,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":146,"category":135,"method":168,"source_type":169,"document":257,"page":189,"section":258,"excerpt":259,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"8.2 Pref. vord. van de fiscus","€ 193.905,00 Toelichting Dit bedrag zal nog verder oplopen.",{"value":124,"state":106,"report_number":151,"report_date":152},{"field":117,"kind":181,"value":118,"state":106,"qualifier":14,"as_of":73,"category":135,"report_number":57,"report_date":73,"source":262,"previous":264,"delta":185,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":143,"category":135,"method":168,"source_type":169,"document":263,"page":189,"section":190,"excerpt":191,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"value":183,"state":106,"report_number":151,"report_date":152},{"field":266,"kind":181,"value":14,"state":267,"qualifier":14,"as_of":14,"category":14,"report_number":14,"report_date":14,"source":14,"previous":14,"delta":14,"curator":14,"processing":45,"correction_pending":45,"conflict":14},"employee_count","not_mentioned",{"count":57,"next":269},{"interval_days":270,"next_on":271},89,"2026-07-06",[273,280,283,290,297,305,312,315,322,325,328,336],{"topic":274,"investigation":45,"state":196,"category":135,"source":275},"lease_contracts",{"id":276,"category":135,"method":168,"source_type":169,"document":277,"page":57,"section":278,"excerpt":279,"certainty":203,"curator_verified_at":14,"processed_at":179},318127,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"1.4 Huur","Afgelopen verslagperiode is een schikking bereikt met de verhuurder over de oplevering, de vaststelling van de diverse vorderingen en de afrekening van 4 de zekerhedenpositie.",{"topic":226,"investigation":63,"state":227,"category":135,"source":281},{"id":229,"category":135,"method":168,"source_type":169,"document":282,"page":231,"section":232,"excerpt":233,"certainty":234,"curator_verified_at":14,"processed_at":235},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"topic":284,"investigation":45,"state":196,"category":135,"source":285},"employees",{"id":286,"category":135,"method":168,"source_type":169,"document":287,"page":59,"section":288,"excerpt":289,"certainty":203,"curator_verified_at":14,"processed_at":235},134803,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 20-6-2025 18 totaal 18",{"topic":291,"investigation":45,"state":196,"category":135,"source":292},"asset_sales",{"id":293,"category":135,"method":168,"source_type":169,"document":294,"page":59,"section":295,"excerpt":296,"certainty":203,"curator_verified_at":14,"processed_at":235},134804,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"3.1 Onroerende zaken","Beschrijving Verkoopopbr. Hypotheek Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 Toelichting onroerende zaken",{"topic":298,"investigation":45,"state":196,"category":135,"source":299},"receivables_collection",{"id":300,"category":135,"method":168,"source_type":169,"document":301,"page":302,"section":303,"excerpt":304,"certainty":203,"curator_verified_at":14,"processed_at":235},134809,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},8,"4.1 Debiteuren","Beschrijving Omvang Opbrengst Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 € 0,00 Toelichting debiteuren Failliet is afhankelijk van investeerders en overheidsinstellingen. Er w erden geen facturen gestuurd.",{"topic":306,"investigation":45,"state":196,"category":135,"source":307},"security_rights",{"id":308,"category":135,"method":168,"source_type":169,"document":309,"page":98,"section":310,"excerpt":311,"certainty":203,"curator_verified_at":14,"processed_at":179},318129,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"5.3 Beschrijving zekerheden","Er is een schikking bereikt met de pandhouder c.q. verhuurder, die inmiddels ook is uitgevoerd. Dit is dus afgerond.",{"topic":194,"investigation":63,"state":196,"category":135,"source":313},{"id":198,"category":135,"method":168,"source_type":169,"document":314,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"topic":316,"investigation":63,"state":227,"category":135,"source":317},"annual_accounts_filing",{"id":318,"category":135,"method":168,"source_type":169,"document":319,"page":209,"section":320,"excerpt":321,"certainty":234,"curator_verified_at":14,"processed_at":235},134817,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},"7.2 Depot jaarrekeningen","De jaarrekening 2023 is gedeponeerd op 4 juli 2024.",{"topic":205,"investigation":63,"state":196,"category":135,"source":323},{"id":207,"category":135,"method":168,"source_type":169,"document":324,"page":209,"section":210,"excerpt":211,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"topic":213,"investigation":63,"state":196,"category":135,"source":326},{"id":215,"category":135,"method":168,"source_type":169,"document":327,"page":209,"section":217,"excerpt":218,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},{"topic":329,"investigation":63,"state":196,"category":135,"source":330},"proceedings",{"id":331,"category":135,"method":168,"source_type":169,"document":332,"page":333,"section":334,"excerpt":335,"certainty":203,"curator_verified_at":14,"processed_at":235},134820,{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},16,"9.1 Naam wederpartijen","Er is niet gebleken van procedures.",{"topic":220,"investigation":63,"state":196,"category":135,"source":337},{"id":222,"category":135,"method":168,"source_type":169,"document":338,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":57,"report_date":73,"published_on":73,"page_count":173,"url":174,"available":63},[340,350,355,363,370],{"id":341,"type":342,"group":88,"category":129,"occurred_at":343,"detected_at":344,"date_basis":345,"payload":346,"from_case":14,"source":14},"01M3SJFSMMPXYSF57HT2H28SJG","publication_added","2026-09-30T00:00:00+00:00","2026-09-30T16:31:13+00:00","source",{"publication_id":347,"type":348,"description":349},"01M3SJFSM4FTZCD4RW2MVXCTP3","termination","Opheffing faillissement wegens gebrek aan baten op 29 september 2026",{"id":351,"type":352,"group":88,"category":129,"occurred_at":353,"detected_at":344,"date_basis":345,"payload":354,"from_case":14,"source":14},"01M3SJFSMQX323HXVS9X469T2G","case_terminated","2026-09-29T00:00:00+00:00",{"status":8,"reason":32},{"id":356,"type":357,"group":20,"category":129,"occurred_at":358,"detected_at":359,"date_basis":345,"payload":360,"from_case":14,"source":14},"01M3SJG819ESJGTAAKMA93J97Z","report_published","2026-08-11T12:00:00+00:00","2026-09-30T16:31:28+00:00",{"report_id":361,"report_number":14,"report_date":99,"title":362,"is_final":45},"01M3SJG6FEAWMH3848H04YH4D5","Financieel verslag  04-08-2026",{"id":364,"type":342,"group":88,"category":129,"occurred_at":365,"detected_at":344,"date_basis":345,"payload":366,"from_case":14,"source":14},"01M3SJFSMHNTZBKNQ3HZNMJF2C","2026-05-13T00:00:00+00:00",{"publication_id":367,"type":368,"description":369},"01M3SJFSM3Z6MEWKZGNM4HV5W9","other","Vereenvoudigde afwikkeling van het faillissement",{"id":371,"type":372,"group":373,"category":135,"occurred_at":374,"detected_at":74,"date_basis":345,"payload":375,"from_case":14,"source":14},"01M43ZPMHXVZN6717B8YS6EP76","financial_changed","financial","2026-04-08T12:00:00+00:00",{"from_report":376,"to_report":377,"from_number":151,"to_number":57,"from_date":152,"to_date":73,"fields":378},"01M3SJG1NNPSYYN830PZWANSXG","01M3SJG386F9XHFPVQ99ZCXF6P",[379,382,389],{"field":104,"from":380,"to":381,"delta":250},{"value":249,"state":106,"qualifier":14},{"value":105,"state":106,"qualifier":14},{"field":383,"from":384,"to":386,"delta":388},"estate_claims",{"value":385,"state":106,"qualifier":14},820,{"value":387,"state":106,"qualifier":14},248327.33,247507.33,{"field":390,"from":391,"to":393,"delta":395},"estate_account_balance",{"value":392,"state":106,"qualifier":14},285544.57,{"value":394,"state":106,"qualifier":14},164753.98,-120790.59,[397,402,407,411],{"kind":398,"id":347,"title":349,"report_number":14,"date":399,"pages":185,"category":129,"url":14,"publication_type":348,"publication_number":400,"stored_at":344,"download_url":401},"publication","2026-09-30","01.obr.25.159.F.1316.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM4FTZCD4RW2MVXCTP3\u002Fdownload",{"kind":403,"id":404,"title":362,"report_number":14,"report_date":99,"date":99,"pages":405,"category":129,"url":406},"report","01M3SJG816Q8VPXB9KRPS86W8P",10,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG816Q8VPXB9KRPS86W8P.pdf",{"kind":398,"id":367,"title":369,"report_number":14,"date":408,"pages":185,"category":129,"url":14,"publication_type":368,"publication_number":409,"stored_at":344,"download_url":410},"2026-05-13","01.obr.25.159.F.1308.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM3Z6MEWKZGNM4HV5W9\u002Fdownload",{"kind":403,"id":171,"title":172,"report_number":57,"report_date":73,"date":73,"pages":173,"category":129,"url":174},{"official":58,"curator":60,"automated":413,"external":60},74,[],[],{"sector":14,"cases":417},[]]